Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilmi Kodaz

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Molecular and Clinical Oncology|December 4, 2014
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumorsHilmi Kodaz, Ilhan Hacibekiroglu, Bulent Erdogan, et al.
Medical Oncology (Northwood, London, England)|December 16, 2014
Impact of bevacizumab on survival outcomes in primary tumor resected metastatic colorectal cancerHilmi Kodaz, Bulent Erdogan, Ilhan Hacibekiroglu, et al.
Bosnian Journal of Basic Medical Sciences|July 26, 2016
Unknown primary adenocarcinomas: a single-center experienceSernaz Uzunoglu, Bulent Erdogan, Hilmi Kodaz, et al.
World Journal of Gastrointestinal Oncology|March 17, 2025
Assessment of new pathological markers in early stage colon cancer: Insights and limitationsBulent Erdogan, Fatma Elif Usturalı Keskin, Erkan Özcan, et al.
Northern Clinics of Istanbul|July 29, 2017
Clinical features of the patient with multiple primary tumors: Single center experienceAli Gokyer, Osman Kostek, Muhammet Bekir Hacioglu, et al.
Medical Oncology (Northwood, London, England)|January 10, 2015
Single-agent bevacizumab is an effective treatment in recurrent glioblastomaIlhan Hacibekiroglu, Hilmi Kodaz, Bulent Erdogan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 28, 2015
Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancerBulent Erdogan, Esma Turkmen, Tülin Deniz Yalta, et al.
Balkan Medical Journal|September 9, 2016
KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell CancerHilmi Kodaz, Ebru Taştekin, Bülent Erdoğan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 26, 2018
Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinomaOsman Kostek, Erdem Yilmaz, Muhammet Bekir Hacıoglu, et al.
Bosnian Journal of Basic Medical Sciences|April 21, 2017
K-RAS and N-RAS mutations in testicular germ cell tumorsBekir Muhammet Hacioglu, Hilmi Kodaz, Bulent Erdogan, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Molecular and Clinical Oncology|December 4, 2014
Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumorsHilmi Kodaz, Ilhan Hacibekiroglu, Bulent Erdogan, et al.
Medical Oncology (Northwood, London, England)|December 16, 2014
Impact of bevacizumab on survival outcomes in primary tumor resected metastatic colorectal cancerHilmi Kodaz, Bulent Erdogan, Ilhan Hacibekiroglu, et al.
Bosnian Journal of Basic Medical Sciences|July 26, 2016
Unknown primary adenocarcinomas: a single-center experienceSernaz Uzunoglu, Bulent Erdogan, Hilmi Kodaz, et al.
World Journal of Gastrointestinal Oncology|March 17, 2025
Assessment of new pathological markers in early stage colon cancer: Insights and limitationsBulent Erdogan, Fatma Elif Usturalı Keskin, Erkan Özcan, et al.
Northern Clinics of Istanbul|July 29, 2017
Clinical features of the patient with multiple primary tumors: Single center experienceAli Gokyer, Osman Kostek, Muhammet Bekir Hacioglu, et al.
Medical Oncology (Northwood, London, England)|January 10, 2015
Single-agent bevacizumab is an effective treatment in recurrent glioblastomaIlhan Hacibekiroglu, Hilmi Kodaz, Bulent Erdogan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|July 28, 2015
Importance of Ki-67 in human epidermal growth factor receptor 2 positive breast cancerBulent Erdogan, Esma Turkmen, Tülin Deniz Yalta, et al.
Balkan Medical Journal|September 9, 2016
KRAS Mutation in Small Cell Lung Carcinoma and Extrapulmonary Small Cell CancerHilmi Kodaz, Ebru Taştekin, Bülent Erdoğan, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|October 26, 2018
Value of MRI apparent diffusion coefficient for assessment of response to sorafenib in hepatocellular carcinomaOsman Kostek, Erdem Yilmaz, Muhammet Bekir Hacıoglu, et al.
Bosnian Journal of Basic Medical Sciences|April 21, 2017
K-RAS and N-RAS mutations in testicular germ cell tumorsBekir Muhammet Hacioglu, Hilmi Kodaz, Bulent Erdogan, et al.
Pageof 3